IIPLA Newsroom Access

Sign in with Google to continue in IP News.

Google SSO gives you the quickest path into the IIPLA newsroom, your reading access, and member-level continuity across articles. The full login page is still available if you prefer another option.

IIPLA News
Thursday, April 30, 2026

Turkish Courts Invalidate Bad Faith 'Clindoxyl' Trademark Registration in Favor of GSK

GSK secures decisive legal victory as Turkish judiciary upholds invalidation of opportunistic trademark registration, reinforcing protections for genuine rights holders.

IIPLA News Deskanonymous access0 articles left this week
Turkish Courts Invalidate Bad Faith 'Clindoxyl' Trademark Registration in Favor of GSK
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

GlaxoSmithKline (GSK) has prevailed in a significant trademark dispute in Türkiye, where courts found that a third party acted in bad faith by registering the 'Clindoxyl' mark after GSK's original registration lapsed. The Turkish judiciary, including the Court of Cassation, confirmed the invalidation of the defendant'…
Related Coverage

Continue in the newsroom

Back to newsroom
TrademarksIndia

Intellectual Property Rights (IPR) in India

India's Intellectual Property (IP) filings rose by 44% in last 5 years, led by a 380% surge in Geographical Indications. Legal & Procedural Simplification of IP laws & rules E.g. Patent examination timeline reduced from 48 months to 31 months and mandatory e-submission for patent documents.

Thursday, April 30, 2026
PatentsGlobal

Ontario Expands IPON Funding with $8 Million Boost for Postsecondary Innovation

The Government of Ontario has announced an additional investment of up to $8 million through Intellectual Property Ontario (IPON), expanding support for intellectual property protection and commercialization at postsecondary institutions. The funding increases IPON’s total postsecondary investment to over $17.5 millio…

Thursday, April 30, 2026